Amer A. Almaiman
- Molecular Biology
- Pathology and Forensic Medicine
- Pharmacology top 10%
- Infectious Diseases
- Epidemiology
- Co-authors
- Sultan Ayesh Mohammed SaghirAyman M. MahmoudMay Bin‐JumahMohammad H. AbukhalilSaleem H. AladailehManal A. AlfwuairesHamza HaniehOmnia E. Hussein
- Topics
- Chemotherapy-induced organ toxicity mitigation (4 papers)Bioactive Compounds and Antitumor Agents (2 papers)Blood donation and transfusion practices (2 papers)
- Journals
- MoleculesAntioxidantsBiomolecules
- Partner nations
- Saudi ArabiaJordanEgypt
In The Last Decade
Amer A. Almaiman
13 papers receiving 465 citations
Peers
Comparison fields: 5 of 111
- Molecular Biology 146
- Pathology and Forensic Medicine 111
- Pharmacology 65
- Infectious Diseases 54
- Epidemiology 43
Countries citing papers authored by Amer A. Almaiman
This map shows the geographic impact of Amer A. Almaiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amer A. Almaiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amer A. Almaiman more than expected).
Fields of papers citing papers by Amer A. Almaiman
This network shows the impact of papers produced by Amer A. Almaiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amer A. Almaiman. The network helps show where Amer A. Almaiman may publish in the future.
Co-authorship network of co-authors of Amer A. Almaiman
This figure shows the co-authorship network connecting the top 25 collaborators of Amer A. Almaiman. A scholar is included among the top collaborators of Amer A. Almaiman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amer A. Almaiman. Amer A. Almaiman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 12 | |
| 3 | 49 | |
| 4 | 62 | |
| 5 | 25 | |
| 6 | 14 | |
| 7 | 7 | |
| 8 | 163 | |
| 9 | 107 | |
| 10 | Effect of testosterone boosters on body functions: Case report. | 7 |
| 11 | Evaluation of Blood Donors and Transfusion Transmitted Infections and their Association with ABO and Rh Blood Groups in Unaizah, Saudi Arabia: A Retrospective Study | 8 |
| 12 | 3 | |
| 13 | 12 | |
| 14 | 0 | |
| 15 | 0 |
About Amer A. Almaiman
Amer A. Almaiman is a scholar working on Toxicology, Management of Technology and Innovation and Complementary and alternative medicine, having authored 15 papers that have together received 476 indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (4 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Blood donation and transfusion practices (2 papers). The work is most often cited by research in Pharmacology (65 citations), Pathology and Forensic Medicine (111 citations) and Complementary and alternative medicine (43 citations). Amer A. Almaiman has collaborated with scholars based in Saudi Arabia, Jordan and Egypt. Frequent co-authors include Sultan Ayesh Mohammed Saghir, Ayman M. Mahmoud, May Bin‐Jumah, Mohammad H. Abukhalil, Saleem H. Aladaileh, Manal A. Alfwuaires, Hamza Hanieh, Omnia E. Hussein, Mousa O. Germoush and Naif A. Al-Gabri. Their work appears in journals such as Molecules, Antioxidants and Biomolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.